Currently, there are 165.56M common shares owned by the public and among those 163.86M shares have been available to trade.
Insiders at the company have transacted a total of 151 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 90 of these insider trades were purchases, accounting for 478,736 shares. Insider sales of the common stock occurred on 61 occasions, with total insider shares sold totaling 308,879 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 20.88, down -2.57%. The company’s stock has a 5-day price change of -2.89% and 21.10% over the past three months. TDOC shares are trading -4.92% year to date (YTD), with the 12-month market performance down to -32.64% lower. It has a 12-month low price of $15.02 and touched a high of $30.41 over the same period. TDOC has an average intraday trading volume of 3.94 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.89%, -0.47%, and -5.05% respectively.
Institutional ownership of Teladoc Health Inc (NYSE: TDOC) shares accounts for 78.13% of the company’s 165.56M shares outstanding.
It has a market capitalization of $3.39B and a beta (3y monthly) value of 1.01. The earnings-per-share (ttm) stands at -$24.66. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.47% over the week and 4.08% over the month.
Analysts forecast that Teladoc Health Inc (TDOC) will achieve an EPS of $Teladoc Health, Inc. for the current quarter, $20.49 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Goldman Sachs Future Health Car while analysts give the company a high EPS estimate of $Teradata Corporation. Comparatively, EPS for the current quarter was $TDSC a year ago. Earnings per share for the fiscal year are expected to increase by 10.57%, and 24.01% over the next financial year.
Looking at the support for the TDOC, a number of firms have released research notes about the stock. DA Davidson stated their Neutral rating for the stock in a research note on January 17, 2024, with the firm’s price target at $33-$22. Barclays coverage for the Teladoc Health Inc (TDOC) stock in a research note released on January 03, 2024 offered a Overweight rating with a price target of $26. Stephens was of a view on April 12, 2023 that the stock is Equal-Weight, while SVB Securities gave the stock Outperform rating on February 23, 2023, issuing a price target of $34. Guggenheim on their part issued Neutral rating on October 24, 2022.
